Holen Sie sich die Stockscreener-App
127.53
2.01%
-2.61
Handel nachbörslich:
127.53
Glaukos Corp Aktie (GKOS) Neueste Nachrichten
GKOS Maintained by Citigroup -- Price Target Raised to $162 - GuruFocus
Clearbridge Investments LLC Lowers Stake in Glaukos Corporation $GKOS - MarketBeat
GKOS Reiterated by BTIG -- Price Target Maintained at $162 - GuruFocus
Stifel reiterates Glaukos stock rating on regulatory optimism By Investing.com - Investing.com South Africa
Stifel reiterates Glaukos stock rating on regulatory optimism - Investing.com
Glaukos Corp stock (US3773221029): analyst reiteration and adoption hopes keep momentum in focus - AD HOC NEWS
Why Is NYSE Composite Watching Glaukos’ iDose TR Adoption Momentum? - Kalkine Media
Midday Stock Roundup: Alignment Healthcare Surges - Orange County Business Journal
A Look At Glaukos (GKOS) Valuation After Recent Share Price Swings - Yahoo Finance
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pfizer (PFE), Dexcom (DXCM) and Glaukos (GKOS) - The Globe and Mail
Glaukos Corp Balance Sheet – XETR:6GJ - TradingView
Glaukos Corp Statistics – XETR:6GJ - TradingView
Glaukos Corp Cash Flow – XETR:6GJ - TradingView
Glaukos Corp Revenue Breakdown – XETR:6GJ - TradingView
Glaukos Corp stock (US3773221029): shares near recent highs as valuation comes into focus - AD HOC NEWS
Here's Why You Should Retain Glaukos Stock in Your Portfolio Now - Yahoo Finance
Glaukos (NYSE: GKOS) investors approve board slate, pay and Ernst & Young - Stock Titan
Glaukos Corp. Hits Day High with Strong 7.43% Intraday Surge - Markets Mojo
Glaukos (GKOS) director Leana Wen granted RSUs and options in 2026 - Stock Titan
Glaukos (NYSE: GKOS) director granted new RSUs and stock options - Stock Titan
Glaukos (GKOS) director Denice Torres granted RSUs and stock options - Stock Titan
Glaukos (GKOS) director Mark Foley receives new RSUs and stock options - Stock Titan
GLAUKOS (GKOS) director David Hoffmeister receives new RSU and option grants - Stock Titan
Glaukos Corp (GKOS) director Kliman receives new RSU and option awards - Stock Titan
Director at Glaukos (NYSE: GKOS) granted new stock units and options - Stock Titan
EBITDA per share of Glaukos Corp – FWB:6GJ - TradingView
Glaukos Corp stock (US3773221029): shares active on NYSE as market watches next catalysts - AD HOC NEWS
Glaukos (GKOS) director exercises 15,000 options at $24.69 - Stock Titan
Goldman Sachs Maintains Glaukos(GKOS.US) With Buy Rating, Maintains Target Price $153 - Moomoo
Glaukos Corp. Stock Hits Day Low of $118.64 Amid Price Pressure - Markets Mojo
Glaukos (GKOS) Faces Selling Pressure Amid iDose Procedure Conce - GuruFocus
Glaukos slides 8% as investors appear to take profits after a strong run, with recent insider-sale filings adding pressure - Quiver Quantitative
Nvidia To Rally More Than 123%? Here Are 10 Top Analyst Forecasts For Thursday - Sahm
GKOS Maintained by BTIG -- Price Target Raised to $162 - GuruFocus
Glaukos wins permanent J-code for Epioxa keratoconus therapy - MSN
BTIG raises Glaukos stock price target to $162 on product pipeline - Investing.com
Glaukos director Kliman sells $703,800 in stock By Investing.com - Investing.com Nigeria
Glaukos Corp stock (US3773221029): 52-week high and fresh insider sale stir investor interest - AD HOC NEWS
Glaukos director Kliman sells $703,800 in stock - Investing.com
Director at Glaukos (NYSE: GKOS) exercises options and sells 5,000 shares - Stock Titan
Glaukos stock hits 52-week high at $146.90 By Investing.com - Investing.com Nigeria
Glaukos stock hits 52-week high at $146.90 - Investing.com UK
Glaukos (GKOS) price target increased by 12.59% to 154.96 - MSN
DNB Asset Management AS Grows Stock Position in Glaukos Corporation $GKOS - MarketBeat
1.21%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):